Glaxosmithkline, LLC
Glaxosmithkline, LLC received $40.5M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 35.3% from $29.9M the year before, and $1.8B since FY2022. Its largest customer is the Department of Defense.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- FRHTPHMZMX47
- CAGE code
- 667E9
- Doing business as
- Glaxosmithkline
- Headquarters
- Durham, NC
- Business size
- Other Than Small Business
- Parent company
- Glaxosmithkline PLC (UEI CR4UZS5SKL15)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Defense | $15K | $1.6B |
| Department of Health and Human Services | $39.6M | $176.2M |
| Department of State | $762K | $3.3M |
| Department of Veterans Affairs | −$22K | $1.7M |
| Department of Justice | $113K | $1.3M |
| Department of Homeland Security | $0 | $316K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | $37.1M | $1.7B |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $3.4M | $112.2M |
| 325411 | Medicinal and Botanical Manufacturing | $514K | $2.1M |
| 423450 | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | $75K | $325K |
| 339112 | Surgical and Medical Instrument Manufacturing | $0 | $127K |
| 339999 | All Other Miscellaneous Manufacturing | $0 | $2K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6505 | Drugs and Biologicals | $1.8B |
| AN12 | Health R&D services; Health Care services; Applied Research | $30.4M |
| AN14 | Health R&D services; Health Care services; R&D Administrative Expenses | $7.8M |
| Q517 | Pharmacy Services | $7.3M |
| R799 | Support- management: Other | $2.1M |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $1.1M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75A50124F61013 | Department of Health and Human Services THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) TO SUPPORT THE COVID-19 FEDERAL RESPONSE- MULTI-DOSE VIALS FOR HHS UNDER IDIQ CONTRACT… | $15.4M | Feb 21, 2027 |
| 75A50124F61014 | Department of Health and Human Services THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL COUNTERMEASURES (MCMS) FOR PANDEMIC INFLUENZA AND EMERGING DISEASES PREPAREDNESS AND… | $18.2M | Feb 21, 2027 |
| 75A50124F61010 | Department of Health and Human Services THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ… | $7.8M | May 21, 2027 |
| 75A50124F61012 | Department of Health and Human Services THE PURPOSE OF THIS HHS TASK ORDER IS TO PROCURE SERVICES FOR THE STORAGE AND STABILITY OF BULK LOTS & FINAL CONTAINERS OF-ADJUVANT( AS03) COVID-19 FUNDS. | $14.0M | May 21, 2027 |
| 75D30123F00001 | Department of Health and Human Services GSK VACCINES STORAGE AND ROTATION CONTRACT | $2.1M | Aug 14, 2027 |
| 19AQMM26F1521 | Department of State 2026 - 2027 FLU VACCINES | $687K | Oct 8, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75D30126F21661 | Department of Health and Human Services EO 14398 FY26 EBOLA ATOVAQUONE PROGUANIL | $75K | Sep 22, 2026 |
| 19AQMM26F1521 | Department of State 2026 - 2027 FLU VACCINES | $687K | Sep 18, 2026 |
| 75A50126F61021 | Department of Health and Human Services FILL/FINISH ADJUVANT (AS03): MULTI-DOSE VIALS | $438K | Aug 28, 2026 |
| W912L726FA017 | Department of Defense HEPATITIS A AND B VACCINES FOR TENNESSEE ARMY NATIONAL GUARD. | $15K | Apr 23, 2026 |
| 75A50126F61020 | Department of Health and Human Services TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN | $493K | Mar 30, 2026 |
| 15F06726F0000234 | Department of Justice GSK VACCINES | $24K | Feb 12, 2026 |
| 19PCRD26K1496 | Department of State MEDICAL SUPPLIES | $25K | Dec 8, 2025 |
| 19PCRD26K1498 | Department of State MEDICAL SUPPLIES | $25K | Dec 8, 2025 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.